Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

PHENTERMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Phentermine Hydrochloride, and when can generic versions of Phentermine Hydrochloride launch?

Phentermine Hydrochloride is a drug marketed by Vitarine, Able, Usl Pharma, Sandoz Inc, Tg United Labs, Sandoz, Ken Lifescience, Abc Holding, Teva, Invagen Pharms, Aurolife Pharma Llc, Lannett, Sun Pharm Inds, Camall, Mikah Pharma, Mikah Pharma Llc, Ivax Pharms, Kvk Tech Inc, Watson Labs, Polygen Pharms, Duramed Pharms Barr, Elite Labs, Ingenus Pharms Nj, Lannett Holdings Inc, Barr, Kvk Tech, Actavis Elizabeth, Prinston Inc, Tg United Inc, and Sun Pharm Inds Inc. and is included in eighty-six NDAs.

The generic ingredient in PHENTERMINE HYDROCHLORIDE is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.

Summary for Tradename: PHENTERMINE HYDROCHLORIDE

Patents:0
Applicants:30
NDAs:86
Suppliers / Packagers: see list46
Bulk Api Vendors: see list24
Clinical Trials: see list1,001
Patent Applications: see list615
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PHENTERMINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: PHENTERMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
TABLET;ORAL085671-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL040527-001Oct 23, 2003DISCNNoNo► Subscribe► Subscribe
Sandoz
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL087223-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sandoz
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL087190-002Approved Prior to Jan 1, 1982AARXNoYes► Subscribe► Subscribe
Kvk Tech Inc
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
TABLET;ORAL203436-001Mar 17, 2017AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot